Invenomic Capital Management LP Fulgent Genetics, Inc. Transaction History
Invenomic Capital Management LP
- $1.99 Billion
- Q1 2025
A detailed history of Invenomic Capital Management LP transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Invenomic Capital Management LP holds 236,172 shares of FLGT stock, worth $4.73 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
236,172
Previous 259,010
8.82%
Holding current value
$4.73 Million
Previous $4.78 Million
16.56%
% of portfolio
0.2%
Previous 0.23%
Shares
4 transactions
Others Institutions Holding FLGT
# of Institutions
197Shares Held
17.7MCall Options Held
379KPut Options Held
52.9K-
Black Rock Inc. New York, NY3.92MShares$78.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.97MShares$39.5 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.17MShares$23.4 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.03MShares$20.6 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN625KShares$12.5 Million0.0% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $607M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...